Cargando…
Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485680/ https://www.ncbi.nlm.nih.gov/pubmed/36148068 http://dx.doi.org/10.3389/fcvm.2022.1011535 |
_version_ | 1784792127189811200 |
---|---|
author | Du, Lixin Li, Zhigang Lan, Peng Huang, Huayu Cheng, Wende |
author_facet | Du, Lixin Li, Zhigang Lan, Peng Huang, Huayu Cheng, Wende |
author_sort | Du, Lixin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9485680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94856802022-09-21 Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status Du, Lixin Li, Zhigang Lan, Peng Huang, Huayu Cheng, Wende Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2022-09-06 /pmc/articles/PMC9485680/ /pubmed/36148068 http://dx.doi.org/10.3389/fcvm.2022.1011535 Text en Copyright © 2022 Du, Li, Lan, Huang and Cheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Du, Lixin Li, Zhigang Lan, Peng Huang, Huayu Cheng, Wende Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status |
title | Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status |
title_full | Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status |
title_fullStr | Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status |
title_full_unstemmed | Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status |
title_short | Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status |
title_sort | effectiveness of sglt2is vs. glp-1ras on cardiovascular and cerebrovascular outcomes in t2d patients according to cvd status |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485680/ https://www.ncbi.nlm.nih.gov/pubmed/36148068 http://dx.doi.org/10.3389/fcvm.2022.1011535 |
work_keys_str_mv | AT dulixin effectivenessofsglt2isvsglp1rasoncardiovascularandcerebrovascularoutcomesint2dpatientsaccordingtocvdstatus AT lizhigang effectivenessofsglt2isvsglp1rasoncardiovascularandcerebrovascularoutcomesint2dpatientsaccordingtocvdstatus AT lanpeng effectivenessofsglt2isvsglp1rasoncardiovascularandcerebrovascularoutcomesint2dpatientsaccordingtocvdstatus AT huanghuayu effectivenessofsglt2isvsglp1rasoncardiovascularandcerebrovascularoutcomesint2dpatientsaccordingtocvdstatus AT chengwende effectivenessofsglt2isvsglp1rasoncardiovascularandcerebrovascularoutcomesint2dpatientsaccordingtocvdstatus |